Obstetrics
News from the FDA/CDC
Most pregnancy-related deaths are preventable
Almost one-third of pregnancy-related deaths occur before delivery, the CDC reported.
Conference Coverage
A gentler approach to gastroschisis improves outcomes
BALTIMORE – It involves sutureless closure and breast milk on day 1.
Conference Coverage
Multiple sclerosis may not flare up after pregnancy
PHILADELPHIA – Exclusive breastfeeding significantly reduced the risk of postpartum relapses.
Conference Coverage
ACOG guidance addresses cardiac contributors to maternal mortality
NASHVILLE, TENN. – The guidance has the potential to make strides toward eliminating preventable maternal death.
From the Editor
Good news for ObGyns: Medical liability claims resulting in payment are decreasing!
Not as good news: Claims settling for a payment of greater than $1 million are increasing
Medical professional liability...
Expert Commentary
Are sweeping efforts to reduce primary CD rates associated with an increase in maternal or neonatal AEs?
Not measurably, according to this analysis of cross-sectional data from 56 hospitals with more than 119,000...
From the Journals
Version success more likely in lower BMI, multiparous breech pregnancies
Previous childbirth, lower BMI, and a larger forebag are all associated with a greater chance of success with external cephalic version in breech...
Drugs, Pregnancy & Lactation
Bipolar disorder during pregnancy: Lessons learned
Sustaining euthymia is perhaps the single most critical principle in managing bipolar women during pregnancy and the postpartum period.
Expert Commentary
The ARRIVE trial: Women’s desideratum versus logistical concerns
Do findings from the ARRIVE trial and subsequent outcomes and cost analyses require a full reconsideration of long-held obstetric...
Expert Commentary
Treating the pregnant patient with opioid addiction
Women are increasingly the face of the opioid epidemic, says this addiction expert, and not receiving the care they need. Here,...
Conference Coverage
Dolutegravir passes late pregnancy test
SEATTLE - In ART-naive women in the third trimester of pregnancy, dolutegravir led to reduced viral load at delivery compared to efavirenz.